Targeted Oncology
Advertisement
Articles by Targeted Oncology
Experts review clinical cases and best practices for managing relapsed/refractory DLBCL.
A key opinion leader provides an overview of emerging data for a promising CD-19 targeted therapy and discusses how it has impacted the treatment paradigm.
Experts in breast oncology review 3 clinical cases of HER2+ breast cancer and discuss individualized treatment approaches for each patient.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Savolitinib Plus Osimertinib Improves PFS, OS in MET-Driven NSCLC
2
T-DXd Improves PFS vs Standard of Care in First-Line HER2-Mutant NSCLC
3
FDA Grants Fast Track Designation to Piktor in Endometrial Cancer
4
FDA Grants Type C Meeting for OST-HER2 OS Data in Osteosarcoma
5